PAVmed Price To Sales vs. Shares Outstanding

PAVM Stock  USD 1.10  0.08  6.78%   
Based on the measurements of profitability obtained from PAVmed's financial statements, PAVmed Inc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess PAVmed's ability to earn profits and add value for shareholders.

PAVmed Price To Sales Ratio

11.54

At this time, PAVmed's Days Sales Outstanding is very stable compared to the past year. As of the 4th of December 2024, Days Of Sales Outstanding is likely to grow to 14.05, while Price To Sales Ratio is likely to drop 11.54. At this time, PAVmed's Change To Netincome is very stable compared to the past year. As of the 4th of December 2024, Net Income Per E B T is likely to grow to 1.02, though Accumulated Other Comprehensive Income is likely to grow to (2.8 B).
For PAVmed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PAVmed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PAVmed Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PAVmed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PAVmed Inc over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Revenue Per Share
0.459
Quarterly Revenue Growth
4.898
Return On Assets
(0.80)
Return On Equity
(13.58)
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PAVmed Inc Shares Outstanding vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PAVmed's current stock value. Our valuation model uses many indicators to compare PAVmed value to that of its competitors to determine the firm's financial worth.
PAVmed Inc is rated below average in price to sales category among its peers. It is rated below average in shares outstanding category among its peers creating about  3,449,603  of Shares Outstanding per Price To Sales. At this time, PAVmed's Price To Sales Ratio is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value PAVmed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

PAVmed Shares Outstanding vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

PAVmed

P/S

 = 

MV Per Share

Revenue Per Share

 = 
3.11 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

PAVmed

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
10.74 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

PAVmed Shares Outstanding Comparison

PAVmed is currently under evaluation in shares outstanding category among its peers.

PAVmed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PAVmed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PAVmed will eventually generate negative long term returns. The profitability progress is the general direction of PAVmed's change in net profit over the period of time. It can combine multiple indicators of PAVmed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-3 B-2.8 B
Operating Income-68.8 M-65.4 M
Net Loss-86.4 M-82.1 M
Income Before Tax-79.3 M-75.3 M
Total Other Income Expense Net-10.5 M-9.9 M
Net Loss-80.3 M-76.3 M
Net Loss-64.2 M-61 M
Income Tax Expense-13 B-12.3 B
Net Interest Income-448 K-470.4 K
Interest Income505 K479.8 K
Non Operating Income Net Other-1.6 M-1.6 M
Change To Netincome18.7 M19.6 M
Net Loss(8.87)(9.32)
Income Quality 0.81  0.51 
Net Income Per E B T 0.81  1.02 

PAVmed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PAVmed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PAVmed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PAVmed's important profitability drivers and their relationship over time.

Use PAVmed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PAVmed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PAVmed will appreciate offsetting losses from the drop in the long position's value.

PAVmed Pair Trading

PAVmed Inc Pair Trading Analysis

The ability to find closely correlated positions to PAVmed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PAVmed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PAVmed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PAVmed Inc to buy it.
The correlation of PAVmed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PAVmed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PAVmed Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PAVmed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PAVmed position

In addition to having PAVmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets ETFs Thematic Idea Now

Emerging Markets ETFs
Emerging Markets ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Emerging Markets ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out Your Equity Center.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
To fully project PAVmed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PAVmed Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PAVmed's income statement, its balance sheet, and the statement of cash flows.
Potential PAVmed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although PAVmed investors may work on each financial statement separately, they are all related. The changes in PAVmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PAVmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.